Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development

Yoo, Stephen; J. Jorgensen, Timothy; R. Kennedy, Ann; D. Boice, John; Shapiro, Alla; C. Hu, Tom; R. Moyer, Brian; B. Grace, Marcy; J. Kelloff, Gary; Fenech, Michael; G.S. Prasanna, Pataje; Norman Coleman, C.

doi:10.1088/0952-4746/34/2/r25

Public

Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development

Published in Journal of Radiological Protection • Apr 14, 2014

Authors:

Stephen Yoo

Timothy J. Jorgensen

Ann R. Kennedy

Abstract

The United States radiation medical countermeasures (MCM) programme for radiological and nuclear incidents has been focusing on developing mitigators for the acute radiation syndrome (ARS) and delayed effects of acute radiation exposure (DEARE), and biodosimetry technologies to provide radiation dos...

Subject

Radiological weapon

Medicine

Risk analysis (engineering)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!